Search

everythinglearnresearchcommunity

for

Search:↓

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

Woodhouse-Sakati Syndrome can include unique symptoms like liver issues and low growth hormone.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Woodhouse-Sakati syndrome shows varied symptoms and genetic differences within families.

AC5 improves hair loss and hair quality with high satisfaction rates.

Visual signs are crucial for accurately diagnosing and treating different types of hair loss in Black patients.

A woman with a rare hair loss condition developed skin cancer in the bald area.

A 12-year-old boy has a rare, harmless hair loss on his chin with no need for treatment.

Stem cell treatment improved life quality and sexual function in women with hair loss.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The criteria help doctors diagnose and treat alopecia areata more effectively.

A new one-step test can quickly identify skin cancer during surgery.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Reflectance confocal microscopy can help tell apart scarring from non-scarring hair loss.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Primary cicatricial alopecia significantly reduces life quality, mainly due to pain and anxiety.

Small bowel lesions in Cronkhite-Canada syndrome persist despite steroid treatment.

1′S-1′-Acetoxychavicol acetate may help treat hair loss by reducing oxidative stress.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Aging hair follicle stem cells can be rejuvenated by inhibiting Cdc42.

Cancer-associated fibroblasts promote tumor growth in skin cancer.